In 2021, the Global Artificial Ventilation and Anaesthesia Masks market were estimated to be worth around USD 2.3 billion. With the increasing expenditure incurred on Artificial Ventilation and Anaesthesia Masks worldwide recently, the market is expected to reach a worth of about USD 3.9 billion by the end of 2032, with a projected CAGR of 5.0% from 2022 to 2032. From 2017 to 2021, the Artificial Ventilation and Anaesthesia Masks Market experienced a growth of 5.7%.
| Attributes | Details |
|---|---|
| Global Artificial Ventilation and Anaesthesia Masks Market Size (2021) | USD 2.3 billion |
| Global Artificial Ventilation and Anaesthesia Masks Market Size (2022) | USD 2.4 billion |
| Projected Market Value (2032) | USD 3.9 billion |
| Global Market Growth Rate (2022 to 2032) | 5% CAGR |
| United States Growth Rate (2022 to 2032) | 4.8% CAGR |
| Key Companies Profiled | CareFusion Corporation; Air Liquide Healthcare; Koninklijke Philips N.V.; Fisher and Paykel Healthcare; ResMed; Ambu A/S; Hamilton Medical; Acutronic Medical Systems; GaleMed; HOFFRICHTER GmbH; Dragerwerk SA |
More than 50% of patients admitted to an intensive care unit (ICU) receive a treatment involving Artificial Ventilation and Anaesthesia Masks. The rising geriatric population is one of the key factors boosting the artificial ventilation and anaesthesia masks market. In 2012, the United Nations projected the geriatric population to rise to over 2 billion by 2050. A rise in the geriatric population often increases chronic diseases such as sleep apnea devices, cancer, COPD, kidney failure, and coronary artery diseases. This boosts the demand for surgical procedures, and in turn, increases the artificial ventilation and anaesthesia masks.
The artificial ventilation and anaesthesia mask market is also boosted by the increasing number of COPD patients. The disease is likely to be the third leading cause of death globally as estimated by WHO. Around 12.7 million adults have been reported to have COPD in the USA alone. The growing need for long-term home care and emergency treatment for lung diseases in adults as well as children is expected to boost demand for artificial ventilation and anaesthesia masks in the near future.
The demand for Artificial Ventilators has increased due to the availability of both, invasive and non-invasive ventilators in the market. Similarly, anaesthesia masks are also available for different cases like full face masks, nasal masks, hybrid masks, oral masks, nasal pillows etc. However, the high cost of artificial ventilation in healthcare is expected to slow the growth of the market in certain developing nations.
Artificial Ventilation and Anaesthesia Masks are used most in operation rooms and account for 51.7% of the market share. From 2017 to 2021, the use of Artificial Ventilation and Anaesthesia Masks in operation rooms has increased with a CAGR of 5.5% and is expected to experience a CAGR of 4.8% in the next ten years, from 2022 to 2032. This is largely due to various policies implemented by governments worldwide to make public healthcare accessible to everyone. Every year, more than 340 million operations are performed worldwide, providing huge opportunities for the Artificial Ventilation and Anaesthesia Masks Market.
Recently, the demand for Artificial Ventilation and Anaesthesia Masks are increasing due to their increasing use in-home care. Especially during the pandemic, when most patients wanted to avoid hospitals.
North America holds the largest market for Artificial Ventilation and Anaesthesia Masks. From 2017 to 2021, the North American Artificial Ventilation and Anaesthesia Masks market experienced a CAGR of 5.3% and is projected to see a CAGR of 4.7% in the next ten years.
According to a study an American is expected to get seven operations done on average in his or her entire lifetime and the number of the USA patients who get any kind of complication from surgery is around 1.5 million thus, increasing the demand for Artificial Ventilation and Anaesthesia Masks.
Another key driving factor in the North American Artificial Ventilation and Anaesthesia Masks Market is the increasing rates of chronic diseases and surgeries in Canada. Approximately 31 out of 100,000 Canadians die from chronic respiratory diseases, as per 2020 reports. And around 2 million surgeries are performed in Canada every year. All these factors are driving the Artificial Ventilation and Anaesthesia Masks Market in North America.
The United States has the largest market for Artificial Ventilation and Anaesthesia Masks, which is projected to reach a valuation of USD 1.4 billion by 2032. From 2017 to 2021, the market in the United States grew at a CAGR of 4.8%. Between 2022 and 2032, the United States is expected to be a market with a USD 509.3 million absolute dollar opportunity.
In the United States, every year 5 million people are admitted to ICUs. The number of Americans that were affected by chronic sleep disorders as per a report published by the National Sleep Foundation in 2012. This is expected to increase the demand for Ventilation Equipment and Anaesthesia Masks in the next ten years as these patients are more likely to visit the emergency department and intensive care unit.
Another reason which is helping in boosting the United States Artificial Ventilation and Anaesthesia masks Market is the introduction of The Affordable Care Act by The United States as more patients are now encouraged to opt for surgical treatments.
China’s market is still in the budding stage. China’s Market is projected to reach a valuation of USD 280.4 million by 2032. From 2017 to 2021, the market in China grew at a CAGR of 4.3%. Between 2022 and 2032, China is expected to be a market with a USD 96.8 million absolute dollar opportunity. In 2020, critical care artificial ventilators and anaesthesia masks made up more than 70% of the overall artificial ventilators and anaesthesia masks market in China.
A key reason for the growth of the Artificial Ventilation and Anaesthesia Masks Market in China is the growing older population in the country. The older population in China is expected to reach 198 million by the year 2025, as per the United States Census Bureau. This provides ample opportunities for players in the Artificial Ventilation and Anaesthesia Masks Market. China also exported the most number of Artificial Ventilators and Anaesthesia Masks worldwide, during the pandemic. China exported 16,000 artificial ventilators and anaesthesia masks in just one month during the pandemic.
In 2021, the leading players in China’s Artificial Ventilation and Anaesthesia Masks were Getinge AB, Dragerwerk AG & Co KGaA, Nihon Kohden Corp and Hamilton Medical AG.
The Market for Artificial Ventilation and Anaesthesia Market in Japan is expected to experience a CAGR of 3.4% in the next ten years with an absolute dollar opportunity of USD 64.8 million. By 2032, the Japanese market for Artificial Ventilation and Anaesthesia Market is expected to be worth USD 226.1 million.
Artificial Ventilation and Anaesthesia Masks market is moderately competitive and has numerous players. Many key companies are now focusing on collaborating on new research and development activities.
The key companies operating in the Artificial Ventilation and Anaesthesia Masks Market are CareFusion Corporation, Air Liquide Healthcare, Koninklijke Philips N.V., Fisher and Paykel Healthcare, ResMed, Ambu A/S, Acutronic Medical Systems, GaleMed, HOFFRICHTER GmbH and Dragerwerk SA.
Some of the recent developments by the key providers of Artificial Ventilation and Anaesthesia Masks are as follows:
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2032
Table 2: Global Market Volume (Units) Forecast by Region, 2017 to 2032
Table 3: Global Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 4: Global Market Volume (Units) Forecast by Application, 2017 to 2032
Table 5: Global Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 6: Global Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 7: North America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 8: North America Market Volume (Units) Forecast by Country, 2017 to 2032
Table 9: North America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 10: North America Market Volume (Units) Forecast by Application, 2017 to 2032
Table 11: North America Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 12: North America Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 13: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 14: Latin America Market Volume (Units) Forecast by Country, 2017 to 2032
Table 15: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 16: Latin America Market Volume (Units) Forecast by Application, 2017 to 2032
Table 17: Latin America Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 18: Latin America Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 19: Europe Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 20: Europe Market Volume (Units) Forecast by Country, 2017 to 2032
Table 21: Europe Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 22: Europe Market Volume (Units) Forecast by Application, 2017 to 2032
Table 23: Europe Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 24: Europe Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 25: East Asia Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 26: East Asia Market Volume (Units) Forecast by Country, 2017 to 2032
Table 27: East Asia Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 28: East Asia Market Volume (Units) Forecast by Application, 2017 to 2032
Table 29: East Asia Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 30: East Asia Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 31: South Asia Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 32: South Asia Market Volume (Units) Forecast by Country, 2017 to 2032
Table 33: South Asia Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 34: South Asia Market Volume (Units) Forecast by Application, 2017 to 2032
Table 35: South Asia Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 36: South Asia Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 37: Oceania Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 38: Oceania Market Volume (Units) Forecast by Country, 2017 to 2032
Table 39: Oceania Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 40: Oceania Market Volume (Units) Forecast by Application, 2017 to 2032
Table 41: Oceania Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 42: Oceania Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Table 43: MEA Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 44: MEA Market Volume (Units) Forecast by Country, 2017 to 2032
Table 45: MEA Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 46: MEA Market Volume (Units) Forecast by Application, 2017 to 2032
Table 47: MEA Market Value (US$ million) Forecast by Risk of Procedure, 2017 to 2032
Table 48: MEA Market Volume (Units) Forecast by Risk of Procedure, 2017 to 2032
Figure 1: Global Market Value (US$ million) by Application, 2022 to 2032
Figure 2: Global Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 3: Global Market Value (US$ million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Volume (Units) Analysis by Region, 2017 to 2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 8: Global Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 9: Global Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 12: Global Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 13: Global Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 14: Global Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 15: Global Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 16: Global Market Attractiveness by Application, 2022 to 2032
Figure 17: Global Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 18: Global Market Attractiveness by Region, 2022 to 2032
Figure 19: North America Market Value (US$ million) by Application, 2022 to 2032
Figure 20: North America Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 21: North America Market Value (US$ million) by Country, 2022 to 2032
Figure 22: North America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 23: North America Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 26: North America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 27: North America Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 28: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 29: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 30: North America Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 31: North America Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 34: North America Market Attractiveness by Application, 2022 to 2032
Figure 35: North America Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 36: North America Market Attractiveness by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ million) by Application, 2022 to 2032
Figure 38: Latin America Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 39: Latin America Market Value (US$ million) by Country, 2022 to 2032
Figure 40: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 41: Latin America Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 44: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 45: Latin America Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 48: Latin America Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 49: Latin America Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 50: Latin America Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 52: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 53: Latin America Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 54: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 55: Europe Market Value (US$ million) by Application, 2022 to 2032
Figure 56: Europe Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 57: Europe Market Value (US$ million) by Country, 2022 to 2032
Figure 58: Europe Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 59: Europe Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 60: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 61: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 62: Europe Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 63: Europe Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 64: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 65: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 66: Europe Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 67: Europe Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 68: Europe Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 69: Europe Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 70: Europe Market Attractiveness by Application, 2022 to 2032
Figure 71: Europe Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 72: Europe Market Attractiveness by Country, 2022 to 2032
Figure 73: East Asia Market Value (US$ million) by Application, 2022 to 2032
Figure 74: East Asia Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 75: East Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 76: East Asia Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 77: East Asia Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 78: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 79: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 80: East Asia Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 81: East Asia Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 82: East Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 83: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 84: East Asia Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 85: East Asia Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 88: East Asia Market Attractiveness by Application, 2022 to 2032
Figure 89: East Asia Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 90: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 91: South Asia Market Value (US$ million) by Application, 2022 to 2032
Figure 92: South Asia Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 93: South Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 94: South Asia Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 95: South Asia Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 96: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 97: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 98: South Asia Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 99: South Asia Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 100: South Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 101: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 102: South Asia Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 103: South Asia Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 104: South Asia Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 105: South Asia Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 106: South Asia Market Attractiveness by Application, 2022 to 2032
Figure 107: South Asia Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 108: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 109: Oceania Market Value (US$ million) by Application, 2022 to 2032
Figure 110: Oceania Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 111: Oceania Market Value (US$ million) by Country, 2022 to 2032
Figure 112: Oceania Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 113: Oceania Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 114: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 115: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 116: Oceania Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 117: Oceania Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 118: Oceania Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 119: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 120: Oceania Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 121: Oceania Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 122: Oceania Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 123: Oceania Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 124: Oceania Market Attractiveness by Application, 2022 to 2032
Figure 125: Oceania Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 126: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 127: MEA Market Value (US$ million) by Application, 2022 to 2032
Figure 128: MEA Market Value (US$ million) by Risk of Procedure, 2022 to 2032
Figure 129: MEA Market Value (US$ million) by Country, 2022 to 2032
Figure 130: MEA Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 131: MEA Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: MEA Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 135: MEA Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 136: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 137: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 138: MEA Market Value (US$ million) Analysis by Risk of Procedure, 2017 to 2032
Figure 139: MEA Market Volume (Units) Analysis by Risk of Procedure, 2017 to 2032
Figure 140: MEA Market Value Share (%) and BPS Analysis by Risk of Procedure, 2022 to 2032
Figure 141: MEA Market Y-o-Y Growth (%) Projections by Risk of Procedure, 2022 to 2032
Figure 142: MEA Market Attractiveness by Application, 2022 to 2032
Figure 143: MEA Market Attractiveness by Risk of Procedure, 2022 to 2032
Figure 144: MEA Market Attractiveness by Country, 2022 to 2032
The global Artificial Ventilation and Anaesthesia Masks Market were valued at USD 2.3 billion in 2021.
Over the projected period, the Artificial Ventilation and Anaesthesia Masks Market are expected to increase at a rate of 5%, reaching a value of USD 3.9 billion by 2032.
The involvement of technology in Artificial Ventilation and Anaesthesia Masks and the growing geriatric population has been adding significant revenues to the market.
The Artificial Ventilation and Anaesthesia Masks Market expanded at 5.7% from 2017 through 2021.
Artificial Ventilation and Anaesthesia Masks are used the most in Operation Rooms. Revenue through this category expanded at a CAGR of 5.5% from 2017 to 2021, and is projected to grow at a CAGR of 4.8% by 2032.
CareFusion Corporation, Air Liquide Healthcare, Koninklijke Philips N.V., ResMed, Ambu A/S, Acutronic Medical Systems, GaleMed, are some of the key players in the Artificial Ventilation and Anaesthesia Masks Industry.
The United States, The United Kingdom, China, Japan and South Korea are expected to drive the most Artificial Ventilation and Anaesthesia Masks.
The United States has the largest market for Artificial Ventilation and Anaesthesia Masks.
Explore Similar Insights
Artificial Ventilation and Anaesthesia Masks Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
